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Introduction
The hypothalamus is a critical brain region that regulates food intake, body weight and glucose homeostasis. The hypothalamus directly senses and controls the metabolic signals from the periphery and projects neuronal inputs to the corresponding tissues and organs, accordingly. In recent years, abundant research has demonstrated that normal reactive oxygen species (ROS) levels produced in mitochondria are vital physiological sensors for hypothalamic glucose and fatty acids (Benani et al. 2007) . ROS are chemically reactive molecules containing oxygen. They are formed as a natural by-product of the normal metabolism of O 2 and have important roles in cell signalling and homeostasis. However, the excessive production of O 2 radicals, superoxide, H 2 O 2 , nitric oxide, and peroxynitrite cause excitotoxicity and impair the energy metabolism of cells. Indeed, elevated ROS production causes cellular dysfunction and death (Gyengesi et al. 2012 ). The endogenous antioxidant system i.e. glutathione peroxidase, superoxide dismutase, catalase, and uric acid serve to convert/ neutralize these ROS to less toxic derivatives, thus preventing the reaction of ROS with DNA, RNA, lipids or proteins. The production of excessive amounts of ROS depletes the endogenous antioxidants resulting in the increased peroxidation of membrane lipids or oxidation of proteins leading to DNA fragmentation and inhibition of the mitochondrial electron transport system (Devasagayam et al. 2004 ). Due to the delicate balance required for efficient cellular function, increased ROS production is thought to be a causative factor in multiple disease states including obesity, and is also regarded as a possible cause of aging (Bonomini et al. 2015 (Figure 1 ). In the hypothalamus, leptin inhibits AMPK; thus leading to decreased food intake and increased energy expenditure (Lim et al. 2010) . SIRT-1 and AMPK activity have been shown to control intracellular energy balance, and SIRT-1, in particular, affects longevity (Lim et al. 2010) . SIRT-1 expression decreases FOXO1 acetylation suggesting that SIRT-1 regulates the central melanocortin system in a FOXO1 dependent manner. In addition, hypothalamic Sirt1 regulates S6K (mTOR pathway) signalling such that, inhibition of the fasting induced Sirt1 activity results in up-regulation of the S6K pathway (Cakir et al. 2009 ). Impaired hypothalamic leptin signalling (leptin resistance) is associated with increased adiposity and obesity. Furthermore, leptin resistance increases with age, as does the incidence of obesity.
Hypothalamic inflammation and increased oxidative stress is thought to be one of the underlying mechanisms of obesity (Cai and Liu 2012; Williams 2012 
Surgical procedure and treatment
Rats were anesthetized with isofluarane (2-3%) and their heads were prepared for surgery.
Animals were placed into a stereotaxic frame and a small incision (1.5 cm) was made over the midline of the skull to expose the landmarks of the cranium (bregma and lambda). The following coordinates were used for injection into the third ventricle: 1.1 mm posterior to bregma and 1.6 mm ventral from the skull surface on the midline (medial fissure), with the nose bar set at 4 mm D r a f t Intracerebroventricular tempol administration in old rats reduces oxidative stress in hypothalamus but does not change STAT3 signalling and SIRT1/ AMPK pathway 6 below the ear bars (below zero). A small hole was drilled through the skull and a 23-gauge stainless steel guide cannula was placed into the third ventricle. 2400 mg of tempol was dissolved in 4 ml saline. Either ACSF (artificial cerebrospinal fluid) or tempol was infused (5µg/min) by an Alzet osmotic mini pump (Alza, Palo Alto, CA) into the lateral ventricle via an implanted cannula as described previously (Scarpace et al. 2007 ). This maintained a tempol dose of 300 µg/ h. The tempol dose was based on our previous study (Erdos et al. 2006 ) and other studies (Kang et al. 2009; Xue et al. 2011 ). The cannula is attached to the mini pumps by a polyethylene (PE)50 tubing long enough to implant on the back, between or slightly posterior to the scapulae. A small incision is made at the base of the neck and a subcutaneous pocket to receive the pump is created by blunt dissection. All the pumps are all filled with ACSF. After a recovery and equilibrium period of a week, the dummy pumps are replaced with saline or tempol containing pumps and brain infusion is continued for 2 more weeks ( Figure 2 ).
Food intake, energy intake and delta body weight
Rats were housed individually and food consumption and body weight were recorded in grams daily throughout the experiment.
Body composition of fat and lean mass
Body composition was assessed using time-domain nuclear magnetic resonance (TD-NMR) in restrained but fully conscious rats (TD-NMR Minispec, Bruker Optics, The Woodlands, TX, USA) 2 days before and 2 weeks after the pump implantation.
Serum leptin
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Enzyme immunoassays were used to determine the levels of leptin (rat leptin ELISA kit, EZRL-83K; Milipore, Massachusetts, USA). Leptin was assayed in fed state blood that was collected at death.
Tissue harvesting and preparation
Rats were euthanized with isofluarane. The circulatory system was perfused with 20 ml of icecold saline, and perirenal and retroperitoneal white adipose tissues (PWAT and RTWAT, respectively), brown adipose tissue (BAT), and hypothalamus were excised. The hypothalamus was removed by making an incision medial to piriform lobes, caudal to the optic chiasm and anterior to the cerebral crus, to a depth of 2 to 3 mm. The hypothalamus was sonicated in 50 mMTris-HCl, pH 6.8, plus protease inhibitors. Protein concentrations were determined using the DC protein assay kit (Bio-Rad, Hercules, CA).
NADPH oxidase activity
NADPH oxidase activity was measured with a lucigenin-enhanced chemiluminescence assay using hypothalamus homogenates. The micro-plate containing approximately 15ug of hypothalamus homogenates was maintained at 37°C while luminescence was recorded using a micro-plate reader. Relative light units were obtained for 30 min in the presence of NADH (474 µm) and lucigenin (218 µM), and background-corrected values were normalized to protein content.
Western Blot Analysis
Briefly, an equal amount of protein for each sample was separated by 10-12.5% SDS-PAGE for 1 hour at 100 mA. After electrophoresis, the proteins were transferred to nitrocellulose 
NADPH subunits
NADPH oxidase subunits (phox p47, p67 and gp91) were assessed by Western blot assays. 10 µg (for phox p47), 5 µg (for p67) and 15µg (for gp91) protein were loaded and antibodies (all from Millipore, Billerica, MA) were used in 1/2000 concentration.
Total antioxidant capacity
Total antioxidant capacity in whole brain homogenates was measured using the total antioxidant capacity kit (Abcam, Cambridge, UK, catalog number: ab65329) according to the manufacturer's instructions. Briefly, plasma was allowed to reduce Cu 2+ for 1.5 h at room temperature. Reduced Cu + was chelated with a colorimetric probe and absorbance was measured at 570 nm. Results were expressed as trolox equivalent according to a trolox standard curve.
Superoxide dismutase (SOD)
Superoxide Dismutase (SOD) activity in whole brain homogenates was determined using a commercial kit (Abcam, ab65354). SOD activity was determined by using xanthine oxidase method based on O2•− generation. The rate of the reduction with a superoxide anion is linearly related to the xanthine oxidase (XO) activity and is inhibited with SOD. The inhibition activity of SOD was determined by a colorimetric method.
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Catalase
Catalase was assessed to determine antioxidant capacity in hypothalamus. 6 µg protein was loaded and antibody (Anti-Catalase; EMD Chemicals) was used in 1/2000 concentration.
Reduced total glutathione (GSH) assay
Glutathione measurements were performed using a modification of the Ellman procedure 
Leptin signalling
Leptin signalling was assessed by total STAT and pSTAT protein which were assayed by 
Results
Prior to tempol treatment, body weight was different across age (p<.001), but not within age groups ( Figure 3 ). Treatment with tempol did not affect food intake or body weight when compared with their respective control. Also, the cumulative food consumption was not significantly different among groups.
Adipose tissue weight at death, as expected, was greater in the aged compared with young animals, but there was no influence with tempol treatment (Table 1) . Similarly, brown adipose tissue (BAT) was more abundant in aged versus young rats with no change with tempol. When percent whole body lean mass and fat mass were examined by TDNMR, both measures were significantly higher in old compared with young rats, but again, there was no difference with tempol treatment (Table 1) .
NADPH oxidase catalyzes the one electron reduction of oxygen into superoxide using either NADPH or NADH as the electron donor. Aged controls had significantly higher level of NADPH oxidase enzyme and this was partially reversed by icv tempol treatment. However, subunits of NADPH oxidase, p-47, p67 and gp-91 were not significantly different among groups (Figure 4 ).
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Total antioxidant capacity and superoxide dismutase activity were determined in whole brain, and antioxidant enzyme levels, including catalyse enzyme and total reduced glutathione, were determined in the hypothalamus. With age, there was a decline in the total antioxidant capacity and superoxide dismutase activity in the brain. Antioxidant capacity was significantly elevated by tempol treatment in old rats, while increase in SOD activity was not significant ( Figure 5 a and b). Hypothalamic catalase levels were significantly lower in old rats (Figure 5c ), however tempol failed to reverse this decline. Total GSH levels in hypothalamus were not different among groups (Fig. 5d ).
At death, several signalling molecules that are normally affected by feeding were examined. The rats were euthanized in the early morning, during a time when feeding is normally minimal, thus these baseline values reflect this non-food consumption state.
SIRT1 was significantly lower (p<0.001) in the hypothalamus of old rats. On the other hand, tempol treatment failed to reverse this decline (Figure 6a ).
No significant change was detected in FOXO1 protein, whereas acP53 was significantly (p<0.05) lower in old controls. Tempol treatment also did not have any effect on either of these signalling molecules (Fig 6b, c) .
The baseline pAMPK levels were increased (p<0.05) with age in the hypothalamus, whereas total AMPK levels remained unchanged. Thus, pAMPK/ AMPK ratio was also significantly higher in old control. Tempol treatment prevented the increased pAMPK and pAMPK/AMPK ratio with age (Fig 6d, e, f ).
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Discussion
Hypothalamic inflammation and increased oxidative stress are thought to be two mechanisms underlying obesity and aging (Cai and Liu 2012; Williams 2012; Erdos et al. 2011) . Tempol, (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), a free radical scavenger, has been shown to decrease sympathetic activity in brain (Lu et al. 2004) ; and possess neuroprotective effects in various models of brain injuries including stroke (Wilcox 2010; Hall et al, 2010; Dohare et al. 2014) . It has been proposed that tempol's neuroprotective efficacy is largely due to its ability to catalytically scavenge peroxynitrite radicals (Xiong et al. 2009 ). In the present study we hypothesized that central infusion of tempol, a free radical scavenger, would reduce oxidative stress in the hypothalamus and decrease food intake/ body weight by affecting leptin signalling through the AMPK/ SIRT1 dependent pathway or pSTAT3 pathway in rats with aged-related obesity. For this purpose, we administered tempol at a dose of 5 µg/ min as a continuous infusion for 2 weeks. In other studies (Kang et al. 2009; Xue et al. 2011) , demonstrated that the effective dose ranged between 1.3 -8.6 µg/ min. Therefore, our dose may be considered as a medium dose.
However, our results indicate that centrally administered tempol neither affected food intake nor body composition (lean and fat mass), despite, the significantly decreased oxidative stress in hypothalamus in old rats by tempol treatment. In the present study, catalase activity, which is responsible for the conversion of hydrogen peroxide to water and oxygen, was slightly increased in young with tempol; but there was no effect in old rats. On the other hand, in aged rats, tempol reduced NADPH oxidase, a marker for oxidative stress, in the hypothalamus. Both total SOD enzyme activity and the antioxidant capacity of the whole brain also decreased significantly with age. Tempol treatment significantly increased brain antioxidant capacity in old rats, whereas a slight, non-significant increase was observed in SOD. Other researchers have shown that tempol treatment was effective in increasing SOD activity and GSH activity in young brains (Ali et al. 2016 ). However, our findings did not confirm any increase in antioxidant enzymes in either brain or hypothalamus.
On the other hand, we detected an increase total antioxidant capacity, which is mainly conferred by non-enzymatic antioxidants. Our findings can be interpreted as tempol's failure to increase the enzymatic antioxidants in aged brain. The possible reason for this failure may be the irreversible decrease in antioxidant enzyme activity that cannot be restored. Hence, early and / or long-term treatment can be the key. Overall, tempol treatment reduced oxidative stress, by enhancing antioxidant system, but failed to alter feeding behaviour, body weight, or body composition, suggesting oxidative stress has a minimal role in aged-related obesity in rats.
Our hypothesis was based on the idea that decreasing oxidative stress would improve aging related obesity and impaired hypothalamic signalling in brain. Aging, however, is a Recently, studies focused on the relation between SIRT-1, AMPK and p53 in terms of caloric restriction and longetivity. P53 is a tumor suppressor protein and regulates autophagy. P53
interacts with SIRT1 and mTOR pathways (Paraiso et al. 2013; Lee and Gu 2013; Salmien et al. 2013; Duan et al. 2013; Carling 2004) . A stress signal like glucose starvation or DNA damage rapidly activates p53 and AMPK. Increases in AMPK can also induce p53. Increased p53 levels results in mTOR inhibition, decreased levels of pS6K, and activation of autophagy (Tucci 2012).
Another downstream marker in this pathway is FOXO1 and its expression in brain was previously shown to decrease with aging in frontal, parietal, occipital cortex and hippocampus (Zemva et al. 2012) . In the present study, FOXO1 levels in the hypothalamus displayed a variation among groups, although without significance. Moreover, acetyl p53 levels were significantly higher in the old rats and tempol had a tendency to increase the levels in old rats.
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We also evaluated the pSTAT3/ STAT3 levels, a marker for leptin signalling; because we previously demonstrated that leptin receptor blockade disrupts body weight regulation (Matheny et al. 2014) . Although there was a tendency for decline of leptin signalling in old versus young, neither baseline levels, nor levels after tempol treatment were significantly different.
In conclusion, these results indicate that although tempol decreases oxidative stress, it fails to modulate leptin-signalling pathways. Moreover, tempol fails to alter feeding behaviour, body Aging is a complicated process, often characterized by increased reactive oxygen species (ROS) and inflammation. Whether this increase is a cause or effect is still unclear. Furthermore, there is evidence that aging and increased ROS production leads to impaired FOXO1, AMPK, and SIRT1 signaling, possibly leading to a decrease in catabolic pathways promoting obesity. Furthermore, leptin resistance is associated with aging, and may further dampen catabolic signaling, which may further inflammation and ROS production. 
